These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients. Johannsson G; Touraine P; Feldt-Rasmussen U; Pico A; Vila G; Mattsson AF; Carlsson M; Korbonits M; van Beek AP; Wajnrajch MP; Gomez R; Yuen KCJ J Clin Endocrinol Metab; 2022 Jun; 107(7):1906-1919. PubMed ID: 35368070 [TBL] [Abstract][Full Text] [Related]
6. Influences on quality of life in GH deficient adults and their effect on response to treatment. Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517 [TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: analysis of the German KIMS data and the Study of Health in Pomerania. Moock J; Albrecht C; Friedrich N; Völzke H; Nauck M; Koltowska-Haggström M; Kohlmann T; Wallaschofski H Eur J Endocrinol; 2009 Jan; 160(1):17-24. PubMed ID: 18974232 [TBL] [Abstract][Full Text] [Related]
9. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database. Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444 [TBL] [Abstract][Full Text] [Related]
10. GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database. Gardner CJ; Mattsson AF; Daousi C; Korbonits M; Koltowska-Haggstrom M; Cuthbertson DJ Eur J Endocrinol; 2015 Apr; 172(4):371-81. PubMed ID: 25583905 [TBL] [Abstract][Full Text] [Related]
12. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis. Tritos NA; Johannsson G; Korbonits M; Miller KK; Feldt-Rasmussen U; Yuen KC; King D; Mattsson AF; Jonsson PJ; Koltowska-Haggstrom M; Klibanski A; Biller BM J Clin Endocrinol Metab; 2014 Jun; 99(6):2018-29. PubMed ID: 24694339 [TBL] [Abstract][Full Text] [Related]
13. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE. Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824 [No Abstract] [Full Text] [Related]
14. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency. Hoybye C; Jönsson P; Monson JP; Koltowska-Häggström M; Hána V; Geffner M; Abs R Eur J Endocrinol; 2007 Nov; 157(5):589-96. PubMed ID: 17984238 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index: a precursor to cost-utility analysis. Kołtowska-Häggström M; Kind P; Monson JP; Jonsson B Clin Endocrinol (Oxf); 2008 Jan; 68(1):122-9. PubMed ID: 17803700 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database. Kreitschmann-Andermahr I; Poll EM; Reineke A; Gilsbach JM; Brabant G; Buchfelder M; Fassbender W; Faust M; Kann PH; Wallaschofski H Growth Horm IGF Res; 2008 Dec; 18(6):472-8. PubMed ID: 18829359 [TBL] [Abstract][Full Text] [Related]
17. Proposal of a clinical response score and predictors of clinical response to 2 years of GH replacement therapy in adult GH deficiency. Schneider HJ; Buchfelder M; Wallaschofski H; Luger A; Johannsson G; Kann PH; Mattsson A Eur J Endocrinol; 2015 Dec; 173(6):843-51. PubMed ID: 26369579 [TBL] [Abstract][Full Text] [Related]
18. The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database. Spielhagen C; Schwahn C; Möller K; Friedrich N; Kohlmann T; Moock J; Kołtowska-Häggström M; Nauck M; Buchfelder M; Wallaschofski H Growth Horm IGF Res; 2011 Feb; 21(1):1-10. PubMed ID: 21093334 [TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction. Yuen KC; Koltowska-Häggström M; Cook DM; Fox JL; Jönsson PJ; Geffner ME; Abs R Eur J Endocrinol; 2013 Oct; 169(4):511-9. PubMed ID: 23904277 [TBL] [Abstract][Full Text] [Related]
20. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board. Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]